PET offers a noninvasive means to assess neoplasms, in view of its sensitivity and accuracy in staging tumors and potentially in monitoring treatment response. The aim of this study was to evaluate newly diagnosed non–small cell lung cancer (NSCLC) for the presence of hypoxia, as indicated by the uptake of 18F-fluoromisonidazole (18F-FMISO), and to examine the relationship of hypoxia to the uptake of 18F-FDG, microvessel density, and other molecular markers of hypoxia. Methods: Twenty-one pa-tients with suspected or biopsy-proven NSCLC were enrolled prospectively in this study. All patients had PET studies with 18F-FMISO and 18F-FDG. Seventeen patients subsequently un-derwent surgery, with analysis performed for tumor markers of angiogenesi...
Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...
Introduction:The prognostic value of quantitative 18F-fluoro-2-deoxy-d-glucose (FDG) uptake on posit...
International audienceThe high rates of failure in the radiotherapy target volume suggest that patie...
Background: Hypoxia is associated with resistance to chemotherapy and radiotherapy and is randomly d...
Hypoxic areas are typically resistant to treatment. However, the fluorine-18-fluoroazomycin-arabinos...
Objective: Increased tumor metabolism and hypoxia are related to poor prognosis in solid tumors, inc...
Lung cancer represents the first cause of death by cancer worldwide and remains a challenging public...
Experimental data suggest that the accumulation of [(18)F]fluorodeoxyglucose (FDG) in malignant tumo...
Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...
Background: Most solid tumors contain inadequately oxygenated (i.e., hypoxic) regions, which tend to...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...
In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC), hypoxia is kno...
Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...
Introduction:The prognostic value of quantitative 18F-fluoro-2-deoxy-d-glucose (FDG) uptake on posit...
International audienceThe high rates of failure in the radiotherapy target volume suggest that patie...
Background: Hypoxia is associated with resistance to chemotherapy and radiotherapy and is randomly d...
Hypoxic areas are typically resistant to treatment. However, the fluorine-18-fluoroazomycin-arabinos...
Objective: Increased tumor metabolism and hypoxia are related to poor prognosis in solid tumors, inc...
Lung cancer represents the first cause of death by cancer worldwide and remains a challenging public...
Experimental data suggest that the accumulation of [(18)F]fluorodeoxyglucose (FDG) in malignant tumo...
Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...
Background: Most solid tumors contain inadequately oxygenated (i.e., hypoxic) regions, which tend to...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...
In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC), hypoxia is kno...
Tumor hypoxia hampers the efficacy of radiotherapy because of its increased resistance to ionizing r...
Introduction:The prognostic value of quantitative 18F-fluoro-2-deoxy-d-glucose (FDG) uptake on posit...
International audienceThe high rates of failure in the radiotherapy target volume suggest that patie...